Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer

Toxicology in Vitro

Volumn 52, Issue , 2018, Pages 243-250

  Polini, Beatrice ^a   Digiacomo, Maria ^a   Carpi, Sara ^a   Bertini, Simone ^a   Gado, Francesca ^a   Saccomanni, Giuseppe ^a   Macchia, Marco ^a   Nieri, Paola ^a   Manera, Clementina ^a   Fogli, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Anticancer activity; Chemoprevention; Oil extracts; Oleacein; Oleocanthal; Skin cancer

Indexed keywords

B RAF KINASE; EPIDERMAL GROWTH FACTOR; EXTRA VIRGIN OLIVE OIL; HYDROXYTYROSOL; MITOGEN ACTIVATED PROTEIN KINASE; OLEACEIN; OLEOCANTHAL; PROTEIN KINASE B; SECOIRIDOID; TYROSOL; UNCLASSIFIED DRUG; ALDEHYDE; ANTINEOPLASTIC AGENT; OLIVE OIL; PHENOL DERIVATIVE; PLANT EXTRACT;

ACTINIC KERATOSIS; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL ASSAY; CELL MIGRATION; CELL VIABILITY; CHROMATOGRAPHY; CLONOGENESIS; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE CELL LINE; NON MELANOMA SKIN CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN CARCINOMA; SKIN SQUAMOUS CELL CARCINOMA CELL LINE; SPHEROID FORMATION; WESTERN BLOTTING; CELL LINE; CELL SURVIVAL; DRUG EFFECT; SKIN TUMOR;

ALDEHYDES; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE; CELL SURVIVAL; HUMANS; OLIVE OIL; PHENOLS; PLANT EXTRACTS; SKIN NEOPLASMS;

EID: 85049324498     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2018.06.021     Document Type: Article

References (30)

1. Adinolfi, B., Carpi, S., Romanini, A., Da Pozzo, E., Castagna, M., Costa, B., Martini, C., Olesen, S.-P., Schmitt, N., Breschi, M.C., Nieri, P., Fogli, S., Analysis of the antitumor activity of Clotrimazole on A375 human melanoma cells. Anticancer Res. 35 (2015), 3781–3786.
2. Akl, M.R., Ayoub, N.M., Mohyeldin, M.M., Busnena, B.A., Foudah, A.I., Liu, Y.-Y., Sayed, K.A.E., Olive phenolics as c-met inhibitors: (−)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models. PLoS One, 9, 2014, e97622, 10.1371/journal.pone.0097622.
3. Beauchamp, G.K., Keast, R.S.J., Morel, D., Lin, J., Pika, J., Han, Q., Lee, C.-H., Smith, A.B., Breslin, P.A.S., Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature 437 (2005), 45–46, 10.1038/437045a.
4. Budiyanto, A., Ahmed, N.U., Wu, A., Bito, T., Nikaido, O., Osawa, T., Ueda, M., Ichihashi, M., Protective effect of topically applied olive oil against photocarcinogenesis following UVB exposure of mice. Carcinogenesis 21 (2000), 2085–2090.
5. Carpi, S., Fogli, S., Polini, B., Montagnani, V., Podestà, A., Breschi, M.C., Romanini, A., Stecca, B., Nieri, P., Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells. Toxicol In Vitro 40 (2017), 272–279, 10.1016/j.tiv.2017.01.018 (Apr, Epub 2017 Jan 26).
6. Cusimano, A., Balasus, D., Azzolina, A., Augello, G., Emma, M.R., Di Sano, C., Gramignoli, R., Strom, S.C., McCubrey, J.A., Montalto, G., Cervello, M., Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation. Int. J. Oncol. 51 (2017), 533–544, 10.3892/ijo.2017.4049.
7. D'Amato, R., Proietti, P., Onofri, A., Regni, L., Esposto, S., Servili, M., Businelli, D., Selvaggini, R., Biofortification (Se): does it increase the content of phenolic compounds in virgin olive oil (VOO)?. PLoS One, 12, 2017, e0176580, 10.1371/journal.pone.0176580.
8. D'Orazio, J., Jarrett, S., Amaro-Ortiz, A., Scott, T., UV radiation and the skin. Int. J. Mol. Sci. 14 (2013), 12222–12248, 10.3390/ijms140612222.
9. Elnagar, A.Y., Sylvester, P.W., Sayed El, K.A., (−)-Oleocanthal as a c-Met inhibitor for the control of metastatic breast and prostate cancers. Planta Med. 77 (2011), 1013–1019, 10.1055/s-0030-1270724.
10. Etnyre, D., Stone, A.L., Fong, J.T., Jacobs, R.J., Uppada, S.B., Botting, G.M., Rajanna, S., Moravec, D.N., Shambannagari, M.R., Crees, Z., Girard, J., Bertram, C., Puri, N., Targeting c-Met in melanoma: mechanism of resistance and efficacy of novel combinatorial inhibitor therapy. Cancer Biol. Ther. 15 (2014), 1129–1141, 10.4161/cbt.29451.
11. Fogli, S., Arena, C., Carpi, S., Polini, B., Bertini, S., Digiacomo, M., Gado, F., Saba, A., Saccomanni, G., Breschi, M.C., Nieri, P., Manera, C., Macchia, M., Cytotoxic activity of oleocanthal isolated from virgin olive oil on human melanoma cells. Nutr. Cancer 68 (2016), 873–877, 10.1080/01635581.2016.1180407.
12. Graness, A., Hanke, S., Boehmer, F.D., Presek, P., Liebmann, C., Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells. Biochem. J. 347 (2000), 441–447.
13. Hu, W., Abstract 1635: mechanistic investigation of neutropenia associated with palbociclib. Cancer Res., 75, 2015, 1635, 10.1158/1538-7445.AM2015-1635.
14. Jemec, G., Kemeny, L., Miech, D., Non-Surgical Treatment of Keratinocyte Skin Cancer. 2009, Springer Science & Business Media.
15. Kang, T.-H., Yoon, G., Kang, I.-A., Oh, H.-N., Chae, J.-I., Shim, J.-H., Natural compound Licochalcone B induced extrinsic and intrinsic apoptosis in human skin melanoma (A375) and squamous cell carcinoma (A431) cells. Phytother. Res. 31 (2017), 1858–1867, 10.1002/ptr.5928.
16. Khanfar, M.A., Bardaweel, S.K., Akl, M.R., Sayed El, K.A., Olive oil-derived oleocanthal as potent inhibitor of mammalian target of rapamycin: biological evaluation and molecular modeling studies. Phytother. Res. 29 (2015), 1776–1782, 10.1002/ptr.5434.
17. Khavari, P.A., Modelling cancer in human skin tissue. Nat. Rev. Cancer 6 (2006), 270–280, 10.1038/nrc1838.
18. Legendre, O., Breslin, P.A.S., Foster, D.A., (−)-Oleocanthal rapidly and selectively induces cancer cell death via lysosomal membrane permeabilization (LMP). Mol. Cell. Oncol., 2015, 10.1080/23723556.2015.1006077.
19. Müller, B.A., Imatinib and its successors—how modern chemistry has changed drug development. Curr. Pharm. Des. 15 (2009), 120–133.
20. Pandey, K.B., Rizvi, S.I., Plant polyphenols as dietary antioxidants in human health and disease. Oxidative Med. Cell. Longev. 2 (2009), 270–278, 10.4161/oxim.2.5.9498.
21. Ratushny, V., Gober, M.D., Hick, R., Ridky, T.W., Seykora, J.T., From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J. Clin. Invest. 122 (2012), 464–472, 10.1172/JCI57415.
22. Rogers, H.W., Weinstock, M.A., Harris, A.R., Hinckley, M.R., Feldman, S.R., Fleischer, A.B., Coldiron, B.M., Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch. Dermatol. 146 (2010), 283–287, 10.1001/archdermatol.2010.19.
23. Schwartz, R.A., Bridges, T.M., Butani, A.K., Ehrlich, A., Actinic keratosis: an occupational and environmental disorder. J. Eur. Acad. Dermatol. Venereol. 22 (2008), 606–615, 10.1111/j.1468-3083.2008.02579.x.
24. Shen, S.-C., Ko, C.-H., Hsu, K.-C., Chen, Y.-C., 3-OH flavone inhibition of epidermal growth factor-induced proliferaton through blocking prostaglandin E2 production. Int. J. Cancer 108 (2004), 502–510, 10.1002/ijc.11581.
25. Tasioula-Margari, M., Tsabolatidou, E., Extraction, separation, and identification of phenolic compounds in virgin olive oil by HPLC-DAD and HPLC-MS. Antioxidants (Basel) 4 (2015), 548–562, 10.3390/antiox4030548.
26. Trakatelli, M., Ulrich, C., del Marmol, V., Euvrard, S., Euvard, S., Stockfleth, E., Abeni, D., Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Br. J. Dermatol. 156:Suppl. 3 (2007), 1–7, 10.1111/j.1365-2133.2007.07861.x.
27. Voiculescu, V., Calenic, B., Ghita, M., Lupu, M., Caruntu, A., Moraru, L., Voiculescu, S., Ion, A., Greabu, M., Ishkitiev, N., Caruntu, C., From normal skin to squamous cell carcinoma: a quest for novel biomarkers. Dis. Markers, 2016, 2016, 4517492, 10.1155/2016/4517492.
28. Wright, T.I., Spencer, J.M., Flowers, F.P., Chemoprevention of nonmelanoma skin cancer. J. Am. Acad. Dermatol., 54, 2006 933–46– quiz 947–50 https://doi.org/10.1016/j.jaad.2005.08.062.
29. Xiao, T., Zhu, J.J., Huang, S., Peng, C., He, S., Du, J., Hong, R., Chen, X., Bode, A.M., Jiang, W., Dong, Z., Zheng, D., Phosphorylation of NFAT3 by CDK3 induces cell transformation and promotes tumor growth in skin cancer. Oncogene 36 (2017), 2835–2845, 10.1038/onc.2016.434.
30. Yadav, V., Denning, M.F., Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration. Mol. Carcinog. 50 (2011), 346–352, 10.1002/mc.20716.